Digital Innovations in Diabetes Care (BioSpectrum Asia Edition, Volume 19 | Issue 11 | November 2024)
“Ultimately, this leads to better health outcomes by making diabetes management more accessible and proactive,” said Yeaseul Park, Co-Founder and Co-President Orange Biomed, USA.
Orange Biomed to Showcase First-Ever Microfluidic-Based A1C Test at MEDICA 2024 During Diabetes Awareness Month
Award-Winning, Novel Single-Cell Analysis Technology in a Device Designed to Accurately Measure A1C from One…
Orange Biomed Recognized Globally with KHF Innovation Award for Pioneering Microfluidic Technology Application
OBM rapid A1c is a Breakthrough Microfluidic-Based Testing Device to Redefine Diabetes Management Worldwide…
Orange Biomed to showcase microfluidic-based A1C test
Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology Meeting…
Press Release: Orange Biomed Unveils World’s First Microfluidic-Based A1C Test at the Diabetes Technology Meeting’s Startup Showcase
Attendees get an early preview of Orange Biomed’s revolutionary A1C testing method, recognized as a groundbreaking solution with anticipated release in 2025…
Download Our Media Kit
For patients with diabetes and healthcare professionals that want an easy-to-use
portable A1c testing device, Orange Biomed…
A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells
In the United States, more than 1 in 5 people with diabetes do not know they have diabetes, and they are at higher risk…
The Role of Corporate Social Responsibility for U.S. Market Entry and Expansion – Expediting Value Across Industries Through Community Efforts
When S. Korean companies attempt to
enter or expand within the U.S. market,
they often confront obstacles due to their…
Orange Biomed acquires ISO 9001 certification for quality management system
Glycated hemoglobin, a glycated protein in which sugar is bound to hemoglobin in red blood cells, is the most important…
CEO Interview: Orange BioMed Revolutionizes Diabetes Management: HbA1c Measurement with a Drop of Blood
Glycated hemoglobin, a glycated protein in which sugar is bound to hemoglobin in red blood cells, is the most important…
Orange Biomed selected as 2023 “First Penguin ” by Korea Credit Guarantee Fund
Orange Biomed, a venture company developing a microfluidic-based glycated hemoglobin measurement medical device…
A New Portable HbA1c Meter—Red Blood Cell Deformability–Based HbA1c Test
In the United States, more than 1 in 5 people with diabetes do not know they have diabetes, and they are at higher risk…
Orange Biomed Reveals Home A1c Test in U.S.
Orange Biomed, a diabetes management tech startup, has launched its OBM rapid A1c test in the U.S.
OBM rapid A1c…
Portable, Pocket-Sized A1c Testing Device Delivers Results in 5 Minutes From Single Blood Drop
Diabetes stands as a primary contributor to mortality rates and accounts for a significant portion of healthcare expenses…
Orange Biomed launches OBM rapid A1c test in the US
Healthcare start-up Orange Biomed has launched its pocket-sized, reusable OBM rapid A1c test in the US to fill the testing…
Diabetes Startup Firm Orange Biomed Launches in U.S.
South Korean startup Orange Biomed announced Wednesday its US launch with…
Orange Biomed to unveil latest technology in San Diego
Orange Biomed, a North Carolina health care startup with cutting-edge diabetes management technology…
Orange Biomed unveils at-home A1c test in the U.S.
Orange Biomed announced today that it commenced a U.S. launch as it looks to fill testing gaps for pre-diabetes and diabetes…
Orange Biomed Launches in U.S. Market to Reduce Inaccuracies in Diabetes Diagnosis for Minorities and Help Manage Diabetes at Home with a Revolutionary POC A1c Test
Orange Biomed, a North Carolina health care startup with cutting-edge diabetes management technology…
11 diabetes tech startups you need to know
The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps…
OBM rapid A1c featured listed in “11 diabetes tech startups you need to know”
The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps and…
Founder Interview: Catch Diabetes ‘Unmet Need’ with Quick, Accurate and Simple Glycated Hemoglobin Management
The number of patients with diabetes and pre-diabetes is rapidly increasing not only in Korea but also around the world…
Orange Biomed Highlighted as Top Technology Presented in Pitchfest Sponsored by Mayo Clinic Collaborative Services
Last February, BDMT Global, an American global business development company, successfully completed the ‘DAC…
Orange Biomed Co-Founder, Yeaseul Park, Featured in Forbes Korea’s 30 Under 30 List
Orange Biomed, established in 2021, succeeded in developing the world’s first glycated hemoglobin measuring…
MIT Technology Interview: Glycated Hemoglobin Biomarker Prevents Diabetic Complications
Orange Biomed developed a glycated
hemoglobin analyzer using microfluidic
technology the size of red blood cells…
Orange Biomed Highlighted in Fortune Korea Expert Opinion Report
In 2021, CEOWorld Magazine ranked S. Korea to
be #1 among global healthcare systems, hardly its first Health Care Index…
Unbundling Diabetes: How tech is transforming the care and management of this disease
For over 100 years, insulin has revolutionized diabetes care by providing patients with a treatment to help manage the disease…
Orange Biomed Develops a Portable HbA1c Analyzer
A technology that can check glycated hemoglobin, which previously had to be measured using expensive…
Orange Biomed Attracts $1.6B Won in Pre-Series A Investment Round from Seoul New Technology Investment Company and Digital Healthcare Partners
‘Orange Biomed’, a diabetes in vitro diagnostic medical device startup, attracted 1.6 billion won in pre-Series A round investment…
“Microengineered Materials with Self-Healing Features for Soft Robotics” Article Recognized as Top Downloaded Article by Wiley
Soft bodied invertebrates and vertebrates have been an inspiration for the development of soft robots.[1, 2] Compared to robots…
